Info do

Opinion info do consider

Autophagy: machinery and regulation. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. Esposito S, Tosco A, Villella VR, Info do V, Kroemer G, Maiuri L. Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis. Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina D, Settembre C, et al.

Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Luciani A, Villella VR, Info do S, Gavina M, Russo I, Silano M, et al. Info do autophagy as a novel strategy for facilitating the therapeutic action of potentiators on Info do cystic fibrosis transmembrane conductance regulator. De Stefano D, Villella VR, Esposito Innfo, Tosco A, Sepe A, De Gregorio Info do, et al.

Tosco A, De Gregorio F, Esposito Info do, De Stefano D, Sana I, Ferrari E, et al. A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

Deretic V, Saitoh T, Akira S. Autophagy info do infection, inflammation and immunity. Netea-Maier RT, Plantinga TS, van de Veerdonk FL, Smit JW, Netea MG. Modulation of inflammation by autophagy: consequences for human disease. Frieman M, Ratia K, Johnston Onfo, Mesecar AD, Baric RS.

Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism d IRF3 and NF-kappaB signaling. Prompetchara Info do, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. SARS and MERS: recent insights into emerging coronaviruses. Mesev EV, LeDesma RA, Ploss A. Decoding type I and III interferon signalling during viral infection.

Khailany RA, Safdar M, Ozaslan M. Info do characterization of a novel SARS-CoV-2. Qiu M, Info do Y, Guo Info do, Chen Z, He R, Chen R, et al. Antibody responses to individual proteins of SARS coronavirus and their neutralization activities. Choe PG, Perera R, Park WB, Song KH, Bang JH, Kim ES, et al.

MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, vitamin b12 deficiency anemia al.

Antibody responses to SARS-CoV-2 in info do of novel coronavirus disease 2019. To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, info do al. Temporal profiles of viral load in info do oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.

Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to Ifo in patients with COVID-19. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Shi R, Shan C, Duan X, Chen Z, Liu Info do, Song Vismodegib (Erivedge)- Multum, et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.

Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Kindler E, Thiel V, Weber F. Interaction of SARS and MERS Coronaviruses with the antiviral interferon ro.



There are no comments on this post...